Onglyza® (saxagliptin) Achieves Primary Safety Endpoint, Demonstrating No...
• SAVOR provides information on cardiovascular safety for Onglyza in the wake of past questions about cardiovascular safety of type 2 diabetes treatments • SAVOR is the largest cardiovascular outcomes...
View Article
More Pages to Explore .....